key: cord-0893887-dkimbdsn
authors: Haitao, Tu; Vermunt, Jane; Abeykoon, Jithma; Ghamrawi, Ranine; Gunaratne, Madugodaralalage; Jayachandran, Muthuvel; Narang, Kavita; Parashuram, Santosh; Suvakov, Sonja; Garovic, Vesna
title: COVID-19 and Sex Differences: Mechanisms and Biomarkers
date: 2020-08-04
journal: Mayo Clin Proc
DOI: 10.1016/j.mayocp.2020.07.024
sha: a4e6b2e8e870f9140538f42f4c146be8d489aa31
doc_id: 893887
cord_uid: dkimbdsn

Abstract Men are consistently overrepresented in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, and COVID (COrona- VIrus-Disease)-19 severe outcomes, including higher fatality rates. These differences are likely due to gender-specific behaviors, genetic and hormonal factors, and sex differences in biological pathways related to SARS-CoV-2 infection. Several social, behavioral and comorbid factors are implicated in the generally worse outcomes in men as compared with women. Underlying biological sex differences and their effects on COVID-19 outcomes, however, have received less attention. The present review summarizes the available literature regarding proposed molecular and cellular markers of COVID-19 infection, their associations with health outcomes, and any reported modification by sex. Biological sex differences characterized by such biomarkers exist within healthy populations and also differ with age- and sex-specific conditions, such as pregnancy and menopause. In the context of COVID-19, descriptive biomarker levels are often reported by sex, but data pertaining to the effect of patient sex on the relationship between biomarkers and COVID-19 disease severity/outcomes are scarce. Such biomarkers may offer plausible explanations for the worse COVID-19 outcomes seen in men. There is the need for larger studies with sex-specific reporting and robust analyses to elucidate how sex modifies cellular and molecular pathways associated with SARS-CoV-2. This will improve interpretation of biomarkers and clinical management of COVID-19 patients by facilitating a personalized medical approach to risk stratification, prevention, and treatment.

Reporting of disaggregated data by sex is uncommonly done in the available literature, and current data relating to COVID-19 and attendant outcomes are no exception. 1 The Global

Health 50/50 have collated international data from countries that provide sex-specific information and report a male to female case fatality ratio ranging from 1.6 to 2.8. 2 National data from China, Korea 3 and Europe report similar case fatality ratios and also a possible interaction with age. 4 Results from observational studies have been consistent, with males and older persons tending to be overrepresented among patients with severe disease, 5-7 ICU admissions, 5, [8] [9] [10] and death from the infection. 3, 7, [11] [12] [13] [14] [15] Studies stratified by sex have also identified male sex as a risk factor for worse outcomes and increased mortality. [16] [17] [18] [19] Large, J o u r n a l P r e -p r o o f robust sex-stratified analyses, however, are limited due to the nature of studying an emerging disease.

The sex disparity of COVID-19 related morbidity and mortality is likely explained by a combination of biological sex differences (differences in chromosomes, reproductive organs and related sex steroids) and gender-specific factors (differential behaviors and activities by social and cultural/traditional roles). 4 Men are more likely to engage in poor health behaviors such as smoking and alcohol consumption, 20, 21 and have higher age adjusted rates of preexisting co-morbidities associated with poor COVID-19 prognosis including hypertension, cardiovascular disease (CVD), and chronic obstructive pulmonary disease (COPD). 7, 9, 13, 18, [22] [23] [24] A stratified analysis by sex furthermore showed that even after adjustment for age, the effect of co-morbidities on COVID-19 mortality was greater for men than women. 16 Various biological pathways may contribute to the differing responses to the SARS-CoV-2 virus by sex. The size and independence of the effect of sex on the association between biomarkers and COVID-19 health outcomes, however, have been rarely reported or translated into preventive and clinical care settings. This review synthesizes the available evidence regarding the proposed cellular and molecular markers of COVID-19 severity by sex, including biomarkers of inflammation; coagulation; liver, renal, and cardiac function; and expression of angiotensin converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2). The available literature on such markers in the general population will also be discussed. The literature regarding biomarkers and COVID-19 available on PubMed, Embase and the Chinese National Knowledge Infrastructure published until June 7th 2020 was systematically searched and J o u r n a l P r e -p r o o f reviewed. Our review synthesizes the current data and identifies the gaps in knowledge regarding the sex differences in COVID-19, which should be addressed in current and future studies in order to personalize evolving screening, preventive, and treatment strategies.

The pathogenesis of SARS-CoV2 disease involves tissues which express high levels of the ACE2 receptor. The infection typically starts in the oropharynx or nasopharynx, and then spreads to tissues that express ACE2: involvement of the upper airway and lungs occurs, the latter potentially leading to pneumonitis. ACE2 is a key negative regulator of the renin-angiotensinaldosterone system (RAAS) and counterbalances the actions of ACE (Figure) . ACE converts angiotensin I (Ang I) to angiotensin II (Ang II), which binds to the angiotensin type 1 receptor (AT1R). This induces many deleterious effects, including vasoconstriction, fluid retention, enhanced cellular growth and migration, and oxidative stress promoting fibrosis and inflammation. 25 ACE and ACE2 share substantive sequence identity, but ACE2 demonstrates substrate specificity and functions exclusively as a monocarboxypeptidase. It removes single Cterminal amino acids from Ang II, generating Ang 1-7 which binds and activates the G-proteincoupled MAS receptor. Ang 1-7 attenuates the harmful effects of Ang II by eliciting a range of effects on the cardiovascular system including vasodilatation; myocardial protection; and effects that are anti-arrhythmic, anti-hypertensive, anti-inflammatory, anti-thrombotic, and inotropic in nature. Ang 1-7 also inhibits pathological cardiac remodeling and insulin resistance. 26, 27 J o u r n a l P r e -p r o o f

The SARS-CoV-2 spike protein interacts with the human cell surface ACE2 receptor, while TMPRSS2 primes the spike protein and may cleave the S1/S2 and S2' sites to assist attachment and membrane fusion. 28, 29 Viral invasion increases activity of A Disintegrin And Metalloproteinase (ADAM) 17 which mediates the release of pro-inflammatory cytokines and ectodomain shedding of ACE2, reducing ACE2 cell surface expression. 30 The protective regulatory effect of the ACE2/Ang 1-7 axis against the RAAS is therefore lost.

Increasing evidence supporting the roles of ACE2 and TMPRSS2 in viral entry and invasion of cells has led to numerous animal and human studies aiming to elucidate the relationship between their expression/function and risk for SARS-CoV-2 infection and COVID-19 severity. In addition, given previously known male/female differences in RAAS, 31 possible sex differences in ACE2 and TMPRSS2 have been postulated, but data are limited. It is likely that chromosomal/genetic differences, together with differential regulation of ACE2 and TMPRSS2 by sex hormones, which is life-cycle dependent, may be relevant considerations. Notably, the ACE2 gene lies on the X-chromosome and escapes X-chromosome inactivation; however, sex specific expression is inconsistent across multiple different tissues. 32 The receptor is predominantly expressed in the lung, heart, vascular endothelium, kidney, testis, gastrointestinal tract and is also shed into circulating plasma. 27 Estrogen (ER) through ER-receptor signaling on myocardium may decrease the ratio of ACE to ACE2 expression and upregulate MAS and angiotensin type 2 receptor (AT2R) expression levels, 33 which, unlike the effect of AT1R activation as described above, reduces inflammation J o u r n a l P r e -p r o o f and tissue fibrosis and promotes tissue repair. 34 A later study however, showed no significant difference in ACE2 expression values in left ventricular tissue between males and females. 35 Preliminary results of an integrated bio-informatics analysis of single-cell RNA sequencing data indicate that the expression of androgen receptors positively correlates with ACE2 and that men may have increased pulmonary alveolar type II cells expressing ACE2 compared to women. 36 Other studies, in contrast, report no significant difference in lung tissue gene expression between males and females, or with differences in age. 35 37, 38 Smoking status, however, appears to correlate with ACE2 gene expression thus implicating differences in gender-specific behaviors. Current smokers as compared with never smokers have significantly upregulated ACE2 expression in the lung and oral epithelium. 38-40 COPD also has been independently associated with increased ACE2 expression by approximately 50% compared to those without COPD. 39 Given that smoking and COPD are more prevalent among males, higher expression of ACE2 due to these risk factors may, in part, explain the worse outcomes in COVID-19 in males. In summary, while studies have reported inconsistent sex differences related to ACE2 expression, it seems that, in general, ACE2 expression is increased in men and decreased in women. These effects may be modified/potentiated by gender-specific factors/behaviors, and should be investigated in future studies dedicated to sex differences.

Observed sex-related differences in the severity of COVID-19 may also be mediated via TMPRSS2 gene expression and activity. The expression of TMPRSS2 on non-sex-specific tissues does not appear to significantly differ between males and females. 35 However, the only known stimulus of TMPRSS2 gene transcription are androgens 41 and, interestingly, patients with COVID-19 who required hospital admission exhibit androgenic alopecia. 42 TMPRSS2 is a J o u r n a l P r e -p r o o f recognized protease associated with prostate cancer, and males with prostate cancer on androgen deprivation therapy may be at a significantly lower risk of SARS-CoV-2 infection as compared with male patients who were not. 43 In addition, one haplotype that upregulates TMPRSS2 expression did so in response to androgens, while another associates with increased risk of severe influenza, the latter also disproportionately affecting males. 44, 45 The risk of severe infection mediated by androgen levels may, in part, explain why preadolescents are usually not severely affected by infection with SARS-CoV-2. However, studies directly comparing the expression of TMPRSS2 by sex and COVID-19 outcomes have not yet been conducted. Future investigation of ACE2 and TMPRSS2 expressions in various tissues and further stratification by sex with respect to disease severity is required.

Morbidity and mortality associated with COVID-19 is mediated through intense viral stimulated inflammation, and increasing levels of inflammatory biomarkers and cytokines, commonly referred to as "cytokine storm." Together with reduced lymphocyte counts, cytokine storm is consistently associated with more severe COVID-19 disease. Among those exhibiting an excessive inflammatory profile, older and male patients are overrepresented. 7, 46, 47 An early elevation in CRP greater than 15 mg/L provides a marker of disease severity 47 and levels >200 mg/L on admission are independently associated with five times the odds of death. 7 Males with severe COVID-19 reportedly have a higher CRP concentration compared to females, independent of age and co-morbidities. 19 Of the numerous interleukins (IL) associated with COVID-19 severity, including IL-6, IL-2, IL-8, IL-10, 46-48 and as compared to females, young and J o u r n a l P r e -p r o o f old males with COVID-19 exhibit significantly higher IL-2 and TNF-alpha, and TNF-alpha levels respectively, independent of co-morbidities. 19 Moreover, data indicate that males with COVID-19 display a greater upregulation of pro-inflammatory cytokines including CCL14, CCL23, IL-7, IL-16, and IL-18, the latter possibly contributing to their higher susceptibility to developing cytokine storm and subsequent poorer COVID-19 outcomes. 36 Although IL-10, a cytokine with anti-inflammatory effects, was shown to be higher among older males, a positive IL-10 feedback could be considered an attempt to decrease excessive inflammation and consequent tissue damage. Further, higher IL-10 expression diminish the activity of antiviral T-cells. 49, 50 Whether biological sex differences modify the associations among CRP and interleukins and COVID-19 outcomes has yet to be examined.

Lymphocytes are among the first responders to viral agents, including SARS-CoV-2, and are associated with COVID-19 severity. 51 Although mild COVID-19 disease can be associated with either increased or decreased lymphocyte count, 52 in severe disease, lymphocytes are consistently decreased. While some COVID-19 studies have suggested that male sex is inversely associated with lymphocyte count 17, 19 a meta-analysis of the mean difference in admission lymphocyte counts between patients with and without severe COVID-19 outcomes showed that lymphopenia and disease severity were not modified by sex or co-morbidities. 53 A single-center Wuhan study showed that in ill patients, concentrations of SARS-CoV-2 IgG were significantly higher in females compared to males, and remained so until 4 weeks from hospital admission. 54 Sex-specific adaptive immune response is generally well recognized, with women J o u r n a l P r e -p r o o f mounting higher antibody production 55 and more efficacious vaccine responses. 55 Healthy females are known to have higher numbers of CD4+ T cells, greater CD4+: CD8+ ratios, increased numbers of activated T cells, cytotoxic T cells, and B cells compared to males, [55] [56] [57] [58] resulting in a prompt response to the presence of infectious agents. The role of sex steroids in the differential immune responses is supported by a study indicating testosterone exerts an immunosuppressant effect, while estrogen may be either immune enhancing 59 or immunosuppressive. 60

Total white cell count was less consistently elevated among COVID-19 patients who required ICU admission or died compared to patients who did not. 12, 47, 61, 62 These studies did not investigate the effect of sex on this relationship, a question that merits attention as there are sex specific differences in blood leukocyte composition within the general population. In the latter population, males have higher baseline numbers of total leukocytes, monocytes, neutrophils, eosinophils, and basophils compared to females. The total leukocyte and neutrophil counts increase progressively until age 55 in males. Women have a bimodal distribution in total leukocyte counts, with the lowest counts occurring around menopause. 63, 64 These known sex differences, together with the presence of underlying co-morbidities and concurrent infections, likely contribute to the inconsistent findings regarding white blood cell counts reported in current COVID-19 studies.

The neutrophil to lymphocyte ratio (NLR) is a well-known marker of inflammation and appears to reflect the severity of COVID-19, particularly among patients older than 50 years of age. 62, 65 J o u r n a l P r e -p r o o f was associated with a lower survival rate. 66 The NLR exhibits distinct sexual dimorphism in the general population. Females 50 years or younger have a higher NLR compared to males of the same age and compared to older females. The NLR is higher for males than females over the age of 50. 63 The effects of sex and age on the prognostic value of NLR require further investigation.

Sex differences may have important implications in the efficacy of therapeutics that target particular viral signaling pathways. Notably, toll-like receptors (TLR), which upregulate type 1 interferon (IFN), an important protective mechanism against viral infections, 67 may be up to 10fold higher in females compared to males. [68] [69] [70] [71] Furthermore, a recent study reported that after TLR7 stimulation, IFN levels were lower in men compared to women. TLR7-mediated IFN expression may be decreased in men due to the known negative effects of testosterone on IFN expression. 70 IFN therapy is under active investigation for COVID-19 patients, so additional research addressing sex differences in the interferon pathway may result in a targeted, sex dependent therapeutic approach.

In addition to deriving benefit from the specific effects of estrogen, females may have stronger immune responses due to the intrinsic differences in the expression of genes on the sex chromosomes. Notably, several genes which contain high numbers of immune-related alleles responsible for innate and adaptive immune responses to infection are located on the Xchromosome. 72 Although X chromosome inactivation is a mechanism of equalizing gene J o u r n a l P r e -p r o o f expression in females and males, some genes such as TLR7 73 may escape silencing, thereby conferring on females an immune advantage over males. 72

One physiological state that is associated with upregulation and increase in ACE2 is normal gestation, which raises the possibility that pregnant women may be at a greater risk for SARS-CoV-2 infection. We have recently reviewed the topic of pregnancy, its complications, and COVID-19. 74 Briefly, the upregulation of ACE2 and consequent conversion of Ang II to Ang 1-7 promote a general state of vasodilation with anti-thrombotic and anti-inflammatory activities in uncomplicated pregnancies. Preeclampsia is a pregnancy-specific, multi-system condition caused by abnormal placental vascular remodeling and systemic endothelial dysfunction which affects 3.3% of pregnancies, 75 and is characterized by decreased maternal plasma Ang 1-7 levels. SARS-CoV-2 directly binds and downregulates ACE2 expression; accordingly, ACE2 protein expression is expected to decrease during such infection. In pregnancy, this may potentiate these RAAS abnormalities because increased Ang II levels, relative to decreased Ang 1-7 levels, occurin preeclampsia (please see Figure 1 ). 74 60 Estrogen depletion or oophorectomy in mice infected with SARS-CoV leads to a worse prognosis compared to normal estrogen producing mice. 80 Clinical studies demonstrate that inflammation resolves more rapidly in women as compared with men, and these differences are thought to be due to hormonal effects on neutrophil apoptosis and bone marrow production. 81, 82 Taken together, available studies provide strong evidence that estrogen exerts significant anti-inflammatory responses, thus suggesting a potential therapeutic role of hormone replacement therapy in older women. Similarly, low levels of testosterone in elderly men have been associated with upregulation of inflammatory markers and possible increased risk of lung damage, as well as respiratory muscle catabolism and increased need for assisted ventilation. 83 As advanced age remains one of the most important risks for poor COVID-19 outcomes, future research should address the role of hormone replacement therapy in elderly women and men who are diagnosed with COVID-19.

Pro calcitonin in females compared to age-matched males, hs-Troponin and CK-MB levels are lower, while NT-proBNP levels are higher. 110, 111 In an acute setting however, sex-specific hs-Troponin and NT-proBNP thresholds do not improve their predictive value of myocardial infarction or death. 111, 112, 113 Despite women having higher baseline NT-proBN, in the setting of acute heart failure the absence of a NT-proBNP sex difference is likely because women more commonly have preserved ejection fraction and less of a rise in NT-proBNP, compared with men who are more likely to develop low ejection fraction heart failure and greater elevations in NT-proBNP levels. 113 108 In addition, NT-proBNP levels are thought to be inversely related to androgen levels. Thus the baseline sex difference is less pronounced as women and men age because estrogen levels decline in women and androgen levels decrease in men. 114 Similar to non-COVID patients, sex was not shown to modify the association between cardiac biomarker levels and patient outcomes among COVID-19 patients in the acute hospital setting. 105

SARS-CoV-2 causes liver damage through varied mechanisms, from direct cellular toxicity to the effects of immune related inflammation; concomitant drug toxicity may contribute to liver damage in patients with Several studies reported increased levels of alanine J o u r n a l P r e -p r o o f aminotransferase (ALT) and aspartate aminotransferase (AST) of between 14 to 53% in COVID-19 affected patients. Significantly higher plasma levels associate with more severe infection and, in some studies, with mortality. 10, 12, 16, 77, [115] [116] [117] One study of 168 patients critically ill with COVID-19 reported significantly higher levels of ALT and AST in males compared to females. 118 Serum transaminase concentrations are generally lower in females compared to males, [119] [120] [121] [122] in part due to differences in fat to muscle ratio, lipid metabolism and hormonal effects on liver cells. 122 Premenopausal women are at lower risk of development of liver inflammation, nonalcoholic steatohepatitis and the resulting increase in cardiovascular risk. 123 Furthermore, elevated ALT may be a predictor of coronary artery disease in males only. 124 With limited reporting on sex differences in liver markers, it is difficult to identify an effect of sex on the prognostic potential of transaminases in COVID-19 patients.

Renal injury occurs in COVID-19. A large prospective cohort study of 701 patients in Wuhan, China, noted that acute kidney injury (AKI) occurred in 5% of patients. 125 This is a lower percentage than is usually observed in other critical illnesses, and renal autopsies performed on COVID-19 patients with AKI showed evidence of renal histologic injury, with varying degrees of acute tubular necrosis. 126 Biomarkers of renal impairment, including an increase in creatinine, blood urine nitrogen (BUN), and presence of AKI have been reported in most studies. 16, 115, 125, 127, 128 Greater elevations in these renal biomarkers along with proteinuria and hematuria occur in critically ill patients compared to patients with mild or moderate infection. 7, 126 Furthermore, independent of age and sex, a higher baseline creatinine, underlying proteinuria, and hematuria were associated with a higher risk of mortality. 12, 47, 126, 127 In patients with severe disease, J o u r n a l P r e -p r o o f creatinine and BUN levels were consistently higher in men compared to women, 17 and older males were more likely to have a higher baseline creatinine and develop AKI, 17, 127 although studies have not investigated the effect of sex on renal biomarkers and COVID-19 severity.

Serum creatinine levels are affected by many factors including, age, sex and muscle mass. The literature regarding susceptibility to AKI based on sex is controversial. A woman's hormonal environment, however, is thought to have a protective effect against the development of AKI, 129, 130 and females have been previously shown to be at lower risk of AKI compared to males. 131 Similarly, smaller studies of renal transplant patients have suggested that male sex may be a risk factor for AKI in COVID-19. 132-134 135 These data set the stage for future studies that should be adequately powered, and likely multicenter, in order to address how the interplay between sex and COVID-19 may affect the incidence of kidney dysfunction, both in native and transplanted kidneys.

Thrombotic diatheses are commonly observed in persons with severe COVID-19. 136 In studies of COVID-19 patients with coagulation dysfunction, the composition of the patient population more commonly includes male patients, and possibly reflects the more severe disease that occurs in males. 12, 140, 144 The underlying mechanism of coagulopathy in COVID-19

patients is yet to be elucidated, but it is hypothesized that a disproportionate inflammatory response results in endothelial cell dysfunction and a pro-thrombotic state. 146 Due to ACE2 receptor expression on endothelial cells, the COVID-19 virus may cause endotheliitis, which could result in not only arterial and venous inflammation, but also microcirculatory and lymphocytic endotheliitis; the consequences of such endotheliitis include widespread organ involvement, sudden vasoconstriction, abnormal angiogenesis, micro thrombi formation and ischemia. [146] [147] [148] Moreover, patients with severe COVID-19 develop a hypercoagulable state, 149 further demonstrated by increased levels of factor VIII and von Willibrand factor, marginally decreased anti-thrombin III activity, 150 and inactivation of the fibrinolytic system. 151 These derangements likely underlie venous thromboses; arterial thromboses that may present as ischemic stroke, mesenteric ischemia and acute limb ischemia; and the phenomenon of freefloating thrombi seen in COVID-19 infection related thrombotic events. 137, [152] [153] [154] [155] Studies of coagulation factors in the general population have consistently shown more favorable profiles for female subjects, and particularly for young women of premenopausal age; such profiles may confer lower risks for thrombotic events compared to men (Table) . Future investigation into the associations of coagulation markers with respect to COVID-19 severity and sex differences would improve understanding of the disease pathology and inform treatment options.

J o u r n a l P r e -p r o o f

The higher COVID-19 case fatality rate and increased severity of disease in males compared to females is likely due to a combination of behavioral/lifestyle risk factors, prevalence of comorbidities, aging, and underlying biological sex differences. Several comorbidities, which disproportionally occur in men likely contribute to worse COVID-19 outcomes, and concerns have been expressed whether ACE inhibitors (ACEi) or angiotensin receptor blockers (ARBs) may exert adverse effects in COVID-19. Experimental and epidemiological evidence is conflicting as to whether the use of ACEi and ARB upregulate ACE2 expression [156] [157] [158] [159] and impacts susceptibility to infection and/or disease severity. Randomized clinical trials in progress may inform recommendations about the use of such therapy in COVID-19 patients and whether this will differ by sex. 160 Based on the available literature, we conclude that biological sex differences may affect the pathogenic mechanisms of COVID-19, the risk for infection, and the severity of the disease, its outcomes, and its biomarkers. Indeed, experimental and epidemiological evidence suggests that most of the biomarkers that have been tested in the context of the risk of infection and the severity of COVID-19 differ by sex at baseline within healthy populations. However, the role of biological sex and risk for infection and disease severity is complex and available data are not uniformly consistent. A notable example is that of the immune response: although females generally have an overall stronger immune response, males are more likely to develop the cytokine storm associated with poor COVID-19 outcomes. Further investigation into immunomodulation by sex hormones, age and X-linked gene expression may help explain the J o u r n a l P r e -p r o o f worse survival of men, and may identify sex-specific risk factors for SARS-CoV-2 infection and the course, outcomes, and prognosis for COVID-19. 

Covid-19 worldwide: we need precise data by age group and sex urgently

Sex, Gender and COVID-19

Disparities in Age-Specific Morbidity and Mortality from SARS-CoV-2 in China and the Republic of Korea

Impact of sex and gender on COVID-19 outcomes in Europe

Clinical Characteristics of Coronavirus Disease 2019 in China

Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital

Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease

High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation

Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Data Analysis of Coronavirus CoVID-19 Epidemic in South Korea Based on Recovered and Death Cases

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China

Case Fatality Rate: Insights From a Multinational Registry

Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Frontiers in Public Health

Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients

Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19

Gendered effects on inflammation reaction and outcome of COVID-19 patients in Wuhan

Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study

a systematic analysis for the Global Burden of Disease Study

Sex differences in coronary heart disease and stroke mortality: a global assessment of the effect of ageing between

Global, regional, and national disability-adjusted lifeyears (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories

Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis

Impact of ACE2 gene polymorphism on antihypertensive efficacy of ACE inhibitors

Chapter 25 -ACE2 Cell Biology, Regulation, and Physiological Functions

Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System

The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade

Can we predict the severity of coronavirus disease 2019 with a routine blood test? Polish Archives of Internal Medicine

Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis

A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: A possible reason underlying different outcome between sex

Sex differences in immune responses

The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20-100 years of age

Reference ranges for lymphocyte subsets in adults from western India: influence of sex, age and method of enumeration

Predominant type 1 CMV-specific memory T-helper response in humans: evidence for gender differences in cytokine secretion

Sex Hormones Determine Immune Response

The complex role of estrogens in inflammation

Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis

Can we predict the severity of coronavirus disease 2019 with a routine blood test? Polish Archives Of Internal Medicine

Difference in Leukocyte Composition between Women before and after Menopausal Age, and Distinct Sexual Dimorphism

Normal haematological values: sex difference in neutrophil count

Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage

Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: A retrospective cross-sectional study

Functional role of type I and type II interferons in antiviral defense

Elevated 17beta-estradiol protects females from influenza A virus pathogenesis by suppressing inflammatory responses

Sex differences in resident immune cell phenotype underlie more efficient acute inflammatory responses in female mice

Sex and Pubertal Differences in the Type 1

Interferon Pathway Associate With Both X Chromosome Number and Serum Sex Hormone Concentration

TLR7 ligands induce higher IFN-alpha production in females

The X chromosome in immune functions: when a chromosome makes the difference

Unusual maintenance of X chromosome inactivation predisposes female lymphocytes for increased expression from the inactive X

SARS-CoV-2 Infection and COVID-19 During Pregnancy: A Multidisciplinary Review

Incidence and Long-Term Outcomes of Hypertensive Disorders of Pregnancy

Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis

Biological Variation of Procalcitonin in Healthy Individuals

Self-Care for Common Colds: The Pivotal Role of Vitamin D, Vitamin C, Zinc, and Echinacea in Three Main Immune Interactive Clusters (Physical Barriers, Innate and Adaptive Immunity) Involved during an Episode of Common Colds-Practical Advice on Dosages and on the Time to Take These Nutrients/Botanicals in order to Prevent or Treat Common Colds

Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials

Vitamin-D and COVID-19: do deficient risk a poorer outcome?

Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data

The association between vitamin D deficiency and communityacquired pneumonia: A meta-analysis of observational studies

Vitamin D deficiency in older men

Vitamin D and Inflammation: Potential Implications for Severity of Covid-19

The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality

25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2

Vitamin D concentrations and COVID-19 infection in UK Biobank

Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Progress in Cardiovascular Diseases

Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan

Prognostic value of NT-proBNP in patients with severe COVID-19

Acute myocardial injury is common in patients with covid-19 and impairs their prognosis

Impact of sex on the prognostic value of highsensitivity cardiac troponin I in the general population: the HUNT study

Sex-Based Differences in Cardiometabolic Biomarkers

Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy

Cardiovascular biomarkers and sex: the case for women

Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Longitudinal association between markers of liver injury and mortality in COVID-19 in China

Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large US Cohort

Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients

Common reference intervals for aspartate aminotransferase (AST), alanine aminotransferase (ALT) and gamma-glutamyl transferase (GGT) in serum: results from an IFCC multicenter study

Updated definitions of healthy ranges for serum alanine aminotransferase levels

Influence of gender on the ratio of serum aspartate aminotransferase (AST) to alanine aminotransferase (ALT) in patients with and without hyperbilirubinemia

Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan

Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens

Sex-influenced association of nonalcoholic fatty liver disease with coronary heart disease

Acute Kidney Injury in Patients Hospitalized with Covid-19. Kidney International

Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia

Kidney disease is associated with in-hospital death of patients with COVID-19

Management of acute kidney injury in patients with COVID-19

Effects of sex hormones on mesangial cells

Influence of Sex on the Progression of Chronic Kidney Disease

Effects of sex hormones on mesangial cells

Early Description of Coronavirus 2019 Disease in Kidney Transplant Recipients in New York

A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia

Early Outcomes of Outpatient Management of Kidney Transplant Recipients with Coronavirus Disease

COVID-19 in solid organ transplant recipients: Initial report from the US epicenter

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan

Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: a retrospective cohort study

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis

Thrombocytopenia and its association with mortality in patients with COVID-19

Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study

Endothelial cell infection and endotheliitis in COVID-19

Clinical Pathology of Critical Patient with Novel Coronavirus Pneumonia

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure

Hypercoagulability of COVID-19 patients in Intensive Care Unit. A Report of Thromboelastography Findings and other Parameters of Hemostasis

Procoagulation, hypercoagulation and fibrinolytic "shut down" detected with ClotPro® viscoelastic tests in COVID-19 patients

Acute ischemic stroke complicating common carotid artery thrombosis during a severe COVID-19 infection

Severe arterial thrombosis associated with Covid-19 infection

Free-floating thrombus of the carotid artery: Literature review and case reports

Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia

Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2

Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan

Circulating plasma concentrations of angiotensinconverting enzyme 2 in men and women with heart failure and effects of reninangiotensin-aldosterone inhibitors

ACE inhibition and cardiometabolic risk factors, lung ACE2 and TMPRSS2 gene expression, and plasma ACE2 levels: a Mendelian randomization study. medRxiv

Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study

Gender-specific and menstrual cycle dependent differences in circulating microparticles

Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study

Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: systematic review and meta-analysis

Sex difference in risk of second but not of first venous thrombosis: paradox explained

Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis

Sex and Race Differences in the Association of Incident Ischemic Stroke With Risk Factors

Myocardial infarction in the young: a sex-based comparison. Coronary Artery Disease

Vascular endothelial estrogen receptor alpha is modulated by estrogen status and related to endothelial function and endothelial nitric oxide synthase in healthy women

Testosterone, hemostasis, and cardiovascular diseases in men

We would like to give special thanks to Joanna King, Creative Director of the Mayo Clinic Biomedical & Science Visualization Medical Illustration team for her help in producing Figure 1 .